tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

BPMC Stock Latest News

Cautious Optimism: Hold Rating Given to Blueprint Medicines Amid Financial Performance Concerns and Slower Ayvakit Growth Projections
RatingsCautious Optimism: Hold Rating Given to Blueprint Medicines Amid Financial Performance Concerns and Slower Ayvakit Growth Projections
6d ago
BPMC
Blueprint Medicines price target raised to $135 from $127 at Baird
PremiumThe Fly
Blueprint Medicines price target raised to $135 from $127 at Baird
9d ago
BPMC
Strong Buy Rating for Blueprint Medicines: Ayvakit’s Growth Potential and Market Opportunities
PremiumRatings
Strong Buy Rating for Blueprint Medicines: Ayvakit’s Growth Potential and Market Opportunities
9d ago
BPMC
Blueprint Medicines Reports Strong Growth and Promising Outlook
PremiumCompany Announcements
Blueprint Medicines Reports Strong Growth and Promising Outlook
9d ago
BPMC
Blueprint Medicines: Positive Earnings Call Highlights Growth
PremiumCompany Announcements
Blueprint Medicines: Positive Earnings Call Highlights Growth
9d ago
BPMC
Strong Market Position and Growth Potential Drive Buy Rating for Blueprint Medicines
PremiumRatingsStrong Market Position and Growth Potential Drive Buy Rating for Blueprint Medicines
9d ago
BPMC
Blueprint Medicines should be bought on any weakness, says Stifel
Premium
The Fly
Blueprint Medicines should be bought on any weakness, says Stifel
10d ago
BPMC
Optimistic Growth Potential and Market Expansion Justify Buy Recommendation for Blueprint Medicines
Premium
Ratings
Optimistic Growth Potential and Market Expansion Justify Buy Recommendation for Blueprint Medicines
10d ago
BPMC
Blueprint Medicines selloff to be short-lived, says Oppenheimer
PremiumThe Fly
Blueprint Medicines selloff to be short-lived, says Oppenheimer
10d ago
BPMC
Blueprint Medicines reports Q4 EPS (79c), consensus (71c)
PremiumThe Fly
Blueprint Medicines reports Q4 EPS (79c), consensus (71c)
10d ago
BPMC
Blueprint Medicines Corp. (BPMC) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Blueprint Medicines Corp. (BPMC) Q4 Earnings Cheat Sheet
12d ago
BPMC
Blueprint Medicines price target raised to $119 from $109 at Piper Sandler
PremiumThe Fly
Blueprint Medicines price target raised to $119 from $109 at Piper Sandler
27d ago
BPMC
Third Harmonic Bio price target lowered to $7 from $15 at Jefferies
PremiumThe FlyThird Harmonic Bio price target lowered to $7 from $15 at Jefferies
1M ago
BPMC
THRD
Blueprint Medicines Highlights 2024 Achievements and Future Growth
Premium
Company Announcements
Blueprint Medicines Highlights 2024 Achievements and Future Growth
1M ago
8K
BPMC
Blueprint Medicines price target lowered to $124 from $135 at Wedbush
Premium
The Fly
Blueprint Medicines price target lowered to $124 from $135 at Wedbush
1M ago
BPMC
CLDX
Opco lists five potential biotech targets into JPMorgan conference
PremiumThe Fly
Opco lists five potential biotech targets into JPMorgan conference
2M ago
XBI
ACLX
Stephens lays out 21 Best Ideas for 2025
PremiumThe Fly
Stephens lays out 21 Best Ideas for 2025
2M ago
FI
SM
Needham adds Axsome to Conviction List, removes Blueprint
PremiumThe Fly
Needham adds Axsome to Conviction List, removes Blueprint
3M ago
AXSM
BPMC
Blueprint Medicines initiated with an Overweight at JPMorgan
PremiumThe Fly
Blueprint Medicines initiated with an Overweight at JPMorgan
3M ago
BPMC
Cogent selloff on ‘old news’ is ‘unwarranted,’ says Citi
PremiumThe FlyCogent selloff on ‘old news’ is ‘unwarranted,’ says Citi
4M ago
BPMC
COGT
Cogent data has positive read-through to Blueprint, says Barclays
Premium
The Fly
Cogent data has positive read-through to Blueprint, says Barclays
4M ago
BPMC
COGT
Blueprint should rally on today’s Cogent data, says Oppenheimer
Premium
The Fly
Blueprint should rally on today’s Cogent data, says Oppenheimer
4M ago
BPMC
COGT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >